Pharma
↔ FADE
AVOID
FDA Macro Bundle: (duplicate/propagation) - See Above (Fade)
Conviction
54%
Edge
DECAYING
Regime
Mixed 55
Freshness
Fresh -
The Opportunity
This is a broad, propagated food-safety/regulatory bundle that the system marks as FADE because Tier-1 coverage has already absorbed the informational advantage. Absent a new primary artefact that ties to a specific issuer or supply-chain disruption, this is background regulatory noise rather than tradable asymmetry.
The Timing
Without a discrete new artefact, this behaves like rolling news. In a Mixed 55 regime with crosswind risk 58, the tape will often reflect macro/breadth moves more than idiosyncratic supply impacts. The trade window closes unless a named company or concrete recall/letter appears.
The Evidence
Upstream includes Tier-1 coverage and regulatory artefacts; the propagation signature is the core reason for FADE and AVOID here.
Disclosure: NOAH Edge publishes this information asymmetry intelligence for transparency. We may hold positions in securities mentioned. This is not financial advice. Always conduct your own due diligence.
9 Apr · Information Asymmetry Report